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The R, -unsaturated aldehydes (enals) acrolein, crotonaldehyde, and trans-4-hydroxynonenal (4-HNE) are products
of endogenous lipid peroxidation, arising as a consequence of oxidative stress. The addition of enals to dG involves
Michael addition of the N2-amine to give N2-(3-oxopropyl)-dG adducts, followed by reversible cyclization of N1
with the aldehyde, yielding 1,N2-dG exocyclic products. The 1,N2-dG exocyclic adducts from acrolein, crotonaldehyde,
and 4-HNE exist in human and rodent DNA. The enal-induced 1,N2-dG lesions are repaired by the nucleotide
excision repair pathway in both Escherichia coli and mammalian cells. Oligodeoxynucleotides containing structurally
deﬁned 1,N2-dG adducts of acrolein, crotonaldehyde, and 4-HNE were synthesized via a postsynthetic modiﬁcation
strategy. Site-speciﬁc mutagenesis of enal adducts has been carried out in E. coli and various mammalian cells. In
all cases, the predominant mutations observed are GfT transversions, but these adducts are not strongly miscoding.
When placed into duplex DNA opposite dC, the 1,N2-dG exocyclic lesions undergo ring opening to the corresponding
N2-(3-oxopropyl)-dG derivatives. Signiﬁcantly, this places a reactive aldehyde in the minor groove of DNA, and
the adducted base possesses a modestly perturbed Watson-Crick face. Replication bypass studies in vitro indicate
that DNA synthesis past the ring-opened lesions can be catalyzed by pol η, pol ι, and pol κ. It also can be accomplished
by a combination of Rev1 and pol   acting sequentially. However, efﬁcient nucleotide insertion opposite the 1,N2-
dG ring-closed adducts can be carried out only by pol ι and Rev1, two DNA polymerases that do not rely on the
Watson-Crick pairing to recognize the template base. The N2-(3-oxopropyl)-dG adducts can undergo further
chemistry, forming interstrand DNA cross-links in the 5′-CpG-3′ sequence, intrastrand DNA cross-links, or
DNA-protein conjugates. NMR and mass spectrometric analyses indicate that the DNA interstand cross-links contain
a mixture of carbinolamine and Schiff base, with the carbinolamine forms of the linkages predominating in duplex
DNA. The reduced derivatives of the enal-mediated N2-dG:N2-dG interstrand cross-links can be processed in
mammalian cells by a mechanism not requiring homologous recombination. Mutations are rarely generated during
processing of these cross-links. In contrast, the reduced acrolein-mediated N2-dG peptide conjugates can be more
mutagenic than the corresponding monoadduct. DNA polymerases of the DinB family, pol IV in E. coli and pol κ
in human, are implicated in error-free bypass of model acrolein-mediated N2-dG secondary adducts, the interstrand
cross-links, and the peptide conjugates.
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1. Introduction
The R, -unsaturated aldehydes (enals) acrolein, crotonalde-
hyde, and trans-4-hydroxynonenal (4-HNE)
1 (Figure 1) are
products of endogenous lipid peroxidation, arising as a conse-
quence of oxidative stress (1-5). Acrolein and crotonaldehyde
are produced during the combustion of organic matter and
exogenous exposure can occur from cigarette smoke and
automobile exhaust (6-10). Sources, metabolism, and biomo-
lecular interactions of acrolein have been reviewed (10). Enals
react with DNA nucleobases to give exocyclic adducts; they
also react with proteins (2, 6). The addition of enals to dG
involves Michael addition of the N2-amine to give N2-(3-
oxopropyl)-dG adducts (1), followed by cyclization of N1 with
the aldehyde (Scheme 1), yielding the corresponding cyclic 1,N2-
dG products (Figure 1).
The principal acrolein adduct is 3-(2′-deoxy- -D-erythro-
pentofuranosyl)-5,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-a]pu-
rin-10(3H)-one (γ-OH-PdG, 2) (Figure 1) (11-13), although
the regioisomeric 3-(2′-deoxy- -D-erythro-pentofuranosyl)-
5,6,7,8-tetrahydro-6-hydroxypyrimido[1,2-a]purin-10(3H)-one
(R-OH-PdG, 3) has also been observed (12-14). The γ-OH-
PdG adduct 2 exists as a mixture of C8-OH epimers. Michael
addition of the N2-atom of dG to higher enals, such as
crotonaldehyde and 4-HNE, creates an additional stereocenter
at C6 of the 1,N2-dG adduct. Four diastereomers are possible
for the crotonaldehyde adducts; the two possessing the trans
relative conﬁgurations at C6 and C8 (4 and 5) are the
predominant species (12, 15, 16). An alternative pathway for
the formation of the crotonaldehyde adducts involves the
reaction of dG with two equivalents of acetaldehyde (17-20).
The corresponding 4-HNE-derived 1,N2-dG adducts possess an
additional stereocenter on the C6 side chain, resulting in four
observable diastereomers (6-9). Acrolein adducts of other
nucleosides have also been characterized (21, 22).
The 1,N2-dG adducts of acrolein (2 and 3), crotonaldehyde
(4 and 5), and 4-HNE (6-9) exist in human and rodent DNA
(3-5, 7, 14, 23-26). In human tissues, these lesions have been
detected at levels ranging from 0.6 to 2000 adducts per 109
guanines (reviewed in ref 5). Both regioisomers of the acrolein
adduct have been detected in lung tissue of smokers (14). The
binding pattern of acrolein-DNA adducts is similar to the p53
mutational pattern in human lung cancer, implicating acrolein
as a possible major cigarette-related lung carcinogen (27). DNA
from liver specimens from individuals suffering from Wilson’s
disease and hemochromatosis contains mutations attributed to
1,N2-dG adducts of 4-HNE (28).
2. Syntheses of Oligodeoxynucleotides Containing
Site-Speciﬁc 1,N2-Deoxyguanosine Adducts Derived
from r, -Unsaturated Aldehydes (Enals)
Aldehyde groups have been introduced into DNA through
periodate cleavage of vicinal diols (29). Johnson’s lab, as well
as ours, synthesized an oligodeoxynucleotide containing N2-
(3,4-dihydroxybutyl)-dG 12 (R ) H) in a sequence-speciﬁc
1 Abbreviations: 4-HNE, trans-4-hydroxynonenal; γ-OH-PdG, 3-(2′-
deoxy- -D-erythro-pentofuranosyl)-5,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-
a]purin-10(3H)-one; R-OH-PdG, 3-(2′-deoxy- -D-erythro-pentofuranosyl)-
5,6,7,8-tetrahydro-6-hydroxypyrimido[1,2-a]purin-10(3H)-one; M1dG, 3-(2′-
deoxy- -D-erythro-pentofuranosyl)pyrimido[1,2-a]purin-10(3H)-one; PdG,
3-(2′-deoxy- -D-erythro-pentofuranosyl)-5,6,7,8-tetrahydropyrimido[1,2-
a]purin-10(3H)-one; pol, polymerase; NER, nucleotide excision repair; XPA,
xeroderma pigmentosum complementation group A; Kf, Klenow fragment
of E. coli polymerase I; TLS, translesion DNA synthesis; PCNA, proliferat-
ing cell nuclear antigen; XPV, xeroderma pigmentosum variant; BER, base
excision repair; Top1, topoisomerase I.
Figure 1. Structures of R, -unsaturated aldehydes acrolein, crotonaldehyde, and 4-HNE and their cyclic 1,N2-dG adducts.
Scheme 1. 1,N2-dG Cyclic Adducts Arising from Michael
Addition of Enals to dG
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verted to the 1,N2-acrolein adduct 13 (R ) H) via periodate
oxidation (Scheme 2) (30). The N2-(3,4-dihydroxybutyl)-dG was
introduced by different approaches. Whereas the Johnson lab
used a suitably protected phosphoramidite reagent of N2-(3,4-
dihydroxybutyl)-dG, we utilized a postsynthetic modiﬁcation
strategy in which oligodeoxynucleotides containing an O6-[(2-
trimethylsilyl)ethyl]-2-ﬂuorohypoxanthine 10 was reacted with
3,4-dihydroxybutylamine (11,R) H) via a nucleophilic
aromatic displacement reaction (Scheme 2) (31, 32). The
postsynthetic modiﬁcation strategy allowed for the preparation
of oligodeoxynucleotides containing dG adducts of crotonal-
dehyde (33) and 4-HNE (34) from a single modiﬁed phosphora-
midite reagent (31, 32). The requisite amino diols 11 for the
crotonaldehyde (R ) CH3) and 4-HNE (R ) CH(OH)C5H11)
adducts were synthesized in enantiomerically pure form to obtain
oligodeoxynucleotides containing stereochemically deﬁned ad-
ducts (20, 34-36). This strategy has been extended to the
preparation of oligodeoxynucleotides containing malondialde-
hyde adducts of dG, 3-(2′-deoxy- -D-erythro-pentofuranosyl)py-
rimido[1,2-a]purin-10(3H)-one (M1dG), and dA (37-39). The
postsynthetic modiﬁcation strategy could not be applied to
oligodeoxynucleotides containing R-OH-PdG adduct 3, which
were prepared using the modiﬁed phosphoramidite approach
(40, 41).
3. Isomerization of Enal-Derived 1,N2-Deoxyguanosine
Adducts to Aldehydes When Placed Opposite dC in
Duplex DNA
The formation of 1,N2-dG annelation products (2-9) blocks
the Watson-Crick hydrogen-bonding face of the nucleobase,
and these adducts were anticipated to be premutagenic lesions.
Earlier studies had focused on the structural characterization of
a model exocyclic adduct, 3-(2′-deoxy- -D-erythro-pentofura-
nosyl)-5,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one (PdG)
14 (Figure 2). NMR analyses revealed that in duplex DNA, PdG
tended to adopt a syn orientation about the glycosyl bond and
formed pairing interactions with the complementary dC via the
Hoogsteen edge (42-44) (Figure 2). Recent NMR studies have
indicated that the acrolein-derived R-OH-PdG adduct 3 also
conserves the ring-closed form and adopts a syn conformation
in duplex DNA (45). Although these structural features are
similar to those previously determined for the model PdG adduct
14 (42-44), the presence of the OH substituent in the former
lesion results in a more stable positioning of the cyclic adduct
in the major groove and a less perturbed DNA structure at the
3′-ﬂanking base pair.
In contrast to the PdG adduct 14 and the R-OH-PdG adduct
3, the M1dG adduct 16 undergoes hydration at C8 and
subsequent ring opening to a related aldehyde adduct, N2-(3-
oxopropenyl)-dG (18), when placed opposite dC in DNA at
neutral pH (Scheme 3) (46-48). NMR structural studies of the
aldehyde 18 in duplex DNA revealed that its formation placed
the N2-(3-oxopropenyl) group in the minor groove, with minimal
DNA structural perturbation, allowing normal Watson-
Crick base pairing (49, 50). Under similar conditions in duplex
DNA, 1,N2-dG enal adducts also undergo ring opening, placing
the N2-(3-oxopropyl) group in the minor groove (51). This was
Scheme 2. Site-Speciﬁc Synthesis of Oligodeoxynucleotides
Containing 1,N2-dG Adducts of Acrolein, Crotonaldehyde,
and 4-HNE by the Postsynthetic Modiﬁcation Strategy
Figure 2. Model substrates for the γ-HO-PdG adduct in DNA. Top
left: PdG (14), a model for the ring-closed form of γ-HO-PdG (2).
Top right: PdG forms a Hoogsteen pair with dC in duplex DNA. Bottom
left: Reduced γ-HO-PdG adduct (15), a model for the ring-opened N2-
(3-oxopropyl)-dG (1). Bottom right: N2-(3-oxopropyl)-dG (1) forms a
Watson-Crick pair with dC in duplex DNA.
Scheme 3. Ring-Opening Chemistry of the M1dG Adduct
Opposite dC in Duplex DNA
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Structural analyses of the acrolein-derived adduct 2 revealed
that the ring-opened aldehyde 1 enabled maintenance of
Watson-Crick base pairing at the lesion site (Scheme 4,
structures shown in box, R ) H) (52). The similar chemistry
(as compared to the M1dG lesion) was consistent with the fact
that enal adducts are lower oxidation state homologues of 16.
With the acrolein adduct 2, ring opening to the aldehyde is
complete at neutral pH.
In contrast to the acrolein adduct 2, the diastereomeric
crotonaldehyde adducts 4 and 5 only partially open to the
respective aldehydes (35). With 4-HNE, the ring-opening
chemistry is more complex (53, 54). When placed complemen-
tary to dC in this duplex, the (6S,8R,11S)- and (6R,8S,11R)-
HNE-dG adducts 6 and 7 open to the corresponding N2-dG
aldehydic products. However, the hydroxyl group of the adduct
side chain reacts with the aldehyde group to afford diastereo-
meric cyclic hemiacetals (27 and 28, Scheme 5). The open-
chain aldehyde and hemiacetal forms exist in equilibrium with
the latter being the predominant species. The trans-relative
stereochemistry of the pentyl side chain and lactol hydroxyl
groups is preferred (53). In all cases, the underlying signiﬁcance
related to the formation of minor groove aldehydes when placed
opposite dC in duplex DNA is that these aldehydes represent
reactive electrophiles that can undergo further chemistry, for
example, formation of DNA-DNA cross-links or DNA-protein
conjugation products (Scheme 4).
4. Mutagenic Consequences of Enal-Derived
1,N2-Deoxyguanosine Adducts
4.1. Acrolein-Derived 1,N2-Deoxyguanosine Adducts. Ac-
rolein is mutagenic in bacterial and mammalian cells (55, 56),
including human ﬁbroblast cells (13, 57, 58), and is carcinogenic
in rats (59). Kawanishi and co-workers examined types of
mutations induced by acrolein in the supF gene of vector DNA
replicated in normal human ﬁbroblasts; the majority of mutations
were base substitutions, predominantly in G:C pairs with a
Scheme 4. Ring-Opening and Cross-Linking Chemistry of 1,N2-Enal-Derived dG Adducts Opposite dC in Duplex DNA
762 Chem. Res. Toxicol., Vol. 22, No. 5, 2009 Minko et al.signiﬁcant number of them being detected at two adjacent bases
(58). Base substitutions in G:C pairs also predominated when
acrolein-treated supF-containing vector was replicated in human
lung ﬁbroblasts; sequences with a run of dGs were the
mutational hotspots (13). Importantly, relative mutagenicity of
acrolein dG adducts, deﬁned as mutant/DNA adduct, was
signiﬁcantly greater than that of UV-induced lesions. Using a
similar approach, Kim and co-workers (60) did not observe a
signiﬁcant increase in mutation frequency in either DNA repair-
proﬁcient or nucleotide excision repair (NER)-deﬁcient human
ﬁbroblasts. They also could not detect mutations in the target
gene within genomic DNA of mouse ﬁbroblasts that were
exposed to acrolein, even though the induction of DNA damage
was conﬁrmed. Taken together, these data suggest that the
mutagenic effect of acrolein adducts is manifested only when
the extent of DNA damage is substantial; they also suggest that
the propensity of acrolein adducts to induce mutations may be
dependent upon variations in biological context, including
speciﬁcs of a particular cellular genetic background and patterns
of gene expression.
The mutagenic properties of acrolein-induced and related
model adducts have also been investigated following replication
of site speciﬁcally modiﬁed vector DNAs in Escherichia coli
and various mammalian cell lines (Table 1). There are two
common experimental strategies that are routinely used to assess
the mutagenic properties of DNA adducts within site speciﬁcally
modiﬁed vector DNAs. One strategy is to investigate mutagenic
consequences following replication of a single-stranded DNA.
Because DNA repair mechanisms utilize the complementary
DNA sequences to restore DNA to its undamaged state, the
possibility that the lesion will be removed prior to replication
is precluded; thus, the major advantage of using a single-
stranded vector is that the mutagenic potential of the lesion can
be directly measured. An alternative approach is to insert the
lesion into a double-stranded vector such that the damaged and
nondamaged strands are marked by distinct sequence signatures.
The advantage of this strategy is that contribution of DNA repair
to cellular processing of the lesion can be assessed. Furthermore,
both the extent of replication blockage caused by the lesion and
the mutagenic outcome of this replication can be simultaneously
evaluated, particularly by utilizing DNA repair-deﬁcient cells.
Moriya and co-workers examined the mutagenic properties
of the PdG adduct 14 (Figure 2) (61), which can serve as a
model for the ring-closed form of the acrolein-derived 1,N2-dG
adducts 2 and 3. The adduct in the CpGpT sequence was
incorporated into a single-stranded vector, and following
replication of the modiﬁed vector in E. coli strain AB1157, GfT
transversions were observed at 100% frequency. When cells
were prechallenged by UV irradiation to induce an SOS
response, an overall mutation frequency was 68%, and in
addition to GfT transversions, other types of base substitutions
were also observed (Table 1, row 1). However, Burcham and
Marnett did not detect any mutations following replication of
PdG-containing double-stranded DNA in noninduced E. coli
strain JM105, when the adduct was positioned in the TpGpT
sequence; in SOS-induced JM105 cells, GfT transversions and
GfA transitions were observed at low frequencies (∼1% of
each type) (Table 1, row 2) (62). The spectra of mutations were
different when PdG was positioned at the second dG of the
repetitive (CpG)3 sequence and replicated in the same JM105
strain. In this case, frameshift mutations consisting of mostly
CG deletions occurred in 2.5% of the progeny DNAs (Table 1,
row 3) (63). In the repetitive (CpG)4 sequence, frameshift
mutations were also detected in the NER-deﬁcient strain that
was derived from AB1157 E. coli but not in the corresponding
NER-proﬁcient strain (Table 1, row 4) (64). The highest
mutation frequency was observed with the PdG modiﬁcation
at the ﬁrst dG of the CpG repeat, followed by adduction at the
fourth and third positions. Thus, the local sequence context and
the genetic background of the bacterial strain can modulate the
mutagenic properties of PdG and probably structurally related
adducts.
The mutagenic properties of γ-OH-PdG 2 have been inves-
tigated in E. coli in three independent studies (Table 1, rows
5-8) (65-67). These studies utilized different vector systems
and assayed bacterial strains with various genetic backgrounds.
In addition, experiments were conducted using both induced
and noninduced cells. Nevertheless, mutations (GfT transver-
sions) were consistently observed at very low frequencies (<1%)
(65, 67) or not detected at all (66).
The PdG adduct 14 induced single base substitutions,
predominantly GfT transversions, at an overall frequency of
∼8% when a single-stranded vector was replicated in African
green monkey kidney (COS-7) cells (Table 1, row 9) (61). The
mutagenic properties of PdG were also investigated in a double-
stranded vector in NER-deﬁcient human xeroderma pigmento-
sum complementation group A (XPA) cells. In this system, the
adduct was also moderately mutagenic; speciﬁcally, it caused
4.6-7.5% base substitutions, mostly GfT transversions (Table
1, row 10) (68, 69). In contrast to PdG, the replication ﬁdelity
of the γ-OH-PdG adduct 2 varied in mammalian cells depending
on whether a single- or double-stranded vector was utilized
(Table 1, rows 11-14). Speciﬁcally, this adduct induced
transversions and transitions at overall frequencies of 3.5-7.4%
in COS-7 cells (67, 70) and ∼11% in normal human ﬁbroblasts
(71) when a single-stranded vector was replicated; the primary
events were GfT transversions. However, γ-OH-PdG was only
Scheme 5. (6S,8R,11S)- and (6R,8S,11R)-4-HNE-dG Adducts
(6 and 7) Form Cyclic Hemiacetals after Initial Ring
Opening Opposite dC in Duplex DNA
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was replicated in HeLa cells (68), and no mutations above the
background levels were detected in XPA cells (68, 69).
Interestingly, the N2-(3-hydroxypropyl)-dG adduct 15, which
cannot form a cyclic adduct and serves as a model for the ring-
opened form of γ-OH-PdG 1 (Figure 2) or its hydrate 19
(Scheme 4), was miscoding only in ∼0.8% of bypass events in
COS-7 cells (Table 1, row 15), even though a single-stranded
vector was used (70). Collectively, these observations suggest
that during replication bypass of γ-OH-PdG in mammalian
systems, mutations are caused primarily by the ring-closed form
of the adduct but not the corresponding ring-opened aldehyde
1 (R ) H). This conclusion is consistent with NMR structural
analyses, showing the ability of the ring-opened adduct to
maintain Watson-Crick hydrogen bonding at the damaged site
(52).
The R-OH-PdG adduct 3 was moderately mutagenic in COS-7
(8.3%) and XPA (12.5 and 10.4%) cells (Table 1, rows 16 and
17) (69, 72), yielding a frequency and spectrum of mutations
similar to PdG (61, 68, 69). The replication of R-OH-PdG in
single-stranded vs double-stranded vectors was comparably
mutagenic, which was also similar to PdG.
4.2. Crotonaldehyde-Derived 1,N2-Deoxyguanosine Ad-
ducts. Crotonaldehyde is mutagenic in bacteria (73), genotoxic
and mutagenic in human lymphoblasts (74), and induces liver
tumors in rodents (75). The mutagenicities of (6R,8R)- and
(6S,8S)-crotonaldehyde adducts 4 and 5 (Table 1, row 18 and
20) were ∼5 and ∼6%, respectively, when a single-stranded,
site speciﬁcally modiﬁed vector was replicated in the COS-7
system (76). GfT transversions were the predominant mutations
for these adducts, followed by GfC transversions and GfA
transitions. Moriya and co-workers examined mutagenic proper-
ties of crotonaldehyde adducts in XPA cells using a double-
stranded vector (77). They observed that the (6R,8R) adduct 4
miscoded at a ∼5% frequency, while the (6S,8S) adduct 5
miscoded at a ∼10% frequency (Table 1, rows 19 and 21). For
both, the major events were GfT transversions, but GfA
transitions were also observed at a comparable level for the
(6R,8R) adduct 4.G fC transversions were the second most
common events for (6S,8S) adduct 5. Signiﬁcantly, both adducts
Table 1. Mutagenic Properties of Enal-Derived and Related 1,N2-Deoxyguanosine Adducts: Effect of Biological Host, DNA
Sequence Context, and Vector System
adduct host sequence context vector mutagenic outcome
1 14 E. coli AB1157 CpGpT single-stranded single base substitutions; 100% of GfT transversions in non-SOS-induced
cells; 51% of GfT transversions, 17% of GfΑ transitions, and <0.5% of
GfC transversions in SOS-induced cells (61)
a
2 14 E. coli JM105 TpGpT double-stranded single base substitutions; no mutations in non-SOS-induced cells; 1% of
GfT transversions and 1% of GfΑ transitions in SOS-induced cells (62)
3 14 E. coli JM105 (CpG)3
b double-stranded frameshift mutations; 2.5%, 70% of which are CG deletions (63)
4 14 E. coli derivatives of AB1157 (CpG)4 double-stranded CG deletions; 0.5% mutations at the ﬁrst dG, 0.1% at the second dG, 0.2%
at the third dG, and 0.3% at the fourth dG in NER-deﬁcient mutant but no
mutations in repair-proﬁcient cells (64)
5 2 E. coli, mismatch repair
deﬁcient derivatives of
MV1932 and NR9232
CpGpA double-stranded one GfT transversions among 282 transformants in non-SOS-induced
MV1932 derivative but no mutations in the same strain following SOS
induction; no mutations in other strains tested including NER mutant (65)
6 2 E. coli derivatives of AB1157 TpGpT double-stranded no mutations (66)
7 2 E. coli derivatives of AB1157 TpGpT single-stranded no mutations (66)
8 2 E. coli AB1157 CpGpA single-stranded single base substitutions; 0.3% of GfT transversions, 0.4% of GfΑ
transitions, and 0.3% of GfC transversions (67)
a
9 14 COS-7 CpGpT single-stranded single base substitutions; 6.9% of GfT and 0.9% of GfC transversions
(61)
a
10 14 XPA CpGpA double-stranded single base substitutions; 5.9 and 3.6% of GfT transversions, 1.0 and 0.4%
of GfΑ transitions, and 0.6 and 0.6% of GfC transversions detected in
two independent studies (68, 69)
a
11 2 COS-7 CpGpA single-stranded single base substitutions; 3.8 and 2.6% of GfT transversions, 1.0 and 0.3%
of GfΑ transitions, and 2.6 and 0.6% of GfC transversions detected in
two independent studies (67, 70)
a
12 2 human ﬁbroblasts CpGpA single-stranded single base substitutions; 8.7% of GfT transversions, 1.1% of GfΑ
transitions, and 1.1% of GfC transversions (71)
a
13 2 HeLa CpGpA double-stranded single base substitutions; 0.5% of GfT transversions and 0.5% of GfΑ
transitions when the adduct was incorporated in the leading strand; 1% of
GfT transversions when the adduct was incorporated in the lagging strand
(68, 69)
a
14 2 XPA CpGpA double-stranded no mutations above background levels (68, 69)
15 15 COS-7 CpGpA single-stranded single base substitutions. 0.8% of GfT transversions (70)
a
16 3 COS-7 CpGpA single-stranded single base substitutions; 5.6% of GfT and 2.6% of GfC transversions (72)
17 3 XPA CpGpA double-stranded single base substitutions; 8.8 and 6.3% of GfT transversions, 1.5 and 1.5%
of GfΑ transitions, and 1.5 and 2.6% of GfC transversions detected in
two independent experiments (69)
a
18 4 COS-7 CpGpA single-stranded single base substitutions; 3.1% of GfT transversions, 0.5% of GfΑ
transitions, and 1.1% of GfC transversions (76)
a
19 4 XPA CpGpA double-stranded single base substitutions; 2.3 and 2.5% of GfT transversions, 1.7 and 1.8%
of GfΑ transitions, and 0.6 and 0.6% of GfC transversions detected in
two independent experiments (77)
a
20 5 COS-7 CpGpA single-stranded single base substitutions; 4.0% of GfT transversions, 1.2% of GfΑ
transitions, and 0.9% of GfC transversions (76)
a
21 5 XPA CpGpA double-stranded single base substitutions; 5.8 and 7.3% of GfT transversions, 0.6 and 0.7%
of GfΑ transitions, and 2.9 and 3.3% of GfC transversions detected in
two independent experiments (77)
a
22 6 COS-7 CpGpA single-stranded single base substitutions; 3.2% of GfT transversions, 0.6% of GfΑ
transitions, and 0.3% of GfC transversions (82)
a
23 7 COS-7 CpGpA single-stranded single base substitutions; 2.9% of GfT transversions, 1.5% of GfΑ
transitions, and 0.6% of GfC transversions (82)
a
24 8 COS-7 CpGpA single-stranded single base substitutions; 0.8% of GfT and 0.3% of GfC transversions
(82)
a
25 9 COS-7 CpGpA single-stranded single base substitutions; 0.25% of GfT and 0.25% of GfC transversions
(82)
a
a For purposes of comparison, percentiles were calculated from primary data that were reported as the number of mutants.
b The adduct was
positioned at the second G of the repetitive sequence.
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but were weaker replication blocks than R-OH-PdG 3. Both
diastereomers 4 and 5 were more miscoding than γ-OH-PdG 2
in a double-stranded vector. Finally, the miscoding potency of
the (6S,8S) adduct 5 was comparable to that of PdG 14 and
R-OH-PdG 3. Overall, these observations suggest that crotonal-
dehyde adducts predominantly exist in the ring-closed form at
the replication fork; this is consistent with the data from NMR
analyses showing that crotonaldehyde adducts are only partially
open to the respective aldehyde forms (35).
4.3. 4-HNE-Derived 1,N2-Deoxyguanosine Adducts.
4-HNE induces a DNA damage response in Salmonella typh-
imurium (78) but is inactive in bacterial mutagenesis assays (55).
The lower homologue 4-hydroxypentenal was found to be
mutagenic in bacteria (55); it was suggested that the cytotoxicity
of 4-HNE masked its genotoxicity. Consistent with this hy-
pothesis are the observations that 4-HNE increases the mutation
rates in the lacZ gene of M13 phage transfected into E. coli
(79) and causes mutations in Chinese hamster lung cells (80)
and human lymphoblastoid cells (28). Mutational spectra have
been determined in the supF gene following replication of a
4-HNE-treated vector DNA in normal human and XPA ﬁbro-
blasts; in both cell types, G:CfT:A transversions were most
prevalent (81). Site-speciﬁc mutagenesis revealed that the
4-HNE-derived 1,N2-dG adducts induced base substitutions at
frequencies of 0.5-5.0% in COS-7 cells (Table 1, rows 22-25);
GfT transversions were the predominant type of mutations.
The adducts having (6S,8R,11S) and (6R,8S,11R) stereochem-
istry (6 and 7) were more mutagenic than the (6S,8R,11R) and
(6R,8S,11S) adducts (8 and 9)( 82).
These data indicate that enal-derived 1,N2-dG adducts are not
strongly miscoding. In all cases, the predominant mutations were
GfT transversions. However, it should be noted that although
deletions and tandem mutations were detected following replica-
tion of randomly modiﬁed vectors (58, 81), no studies have been
conducted to evaluate mutagenicity of enal adducts in deletion-
and tandem mutation-prone repetitive sequences. Such studies
would be of interest since both the PdG and the M1dG adducts
were shown to induce two-base deletions in the repetitive CpG
dinucleotide sequences in E. coli (63, 64), and M1dG caused
this type of mutation in mammalian cells (64).
5. Replication Bypass of Enal-Derived
1,N2-Deoxyguanosine Adducts
5.1. Replication Bypass of Acrolein-Derived 1,N2-Deoxy-
guanosine Adducts by E. coli DNA Pols. As discussed above,
replication bypass of the γ-OH-PdG adduct 2 is nearly error-
free in E. coli (65-67); the level of inhibition of DNA synthesis
past the lesion was estimated at ∼27% (65). Several biochemical
studies have been conducted to examine which E. coli poly-
merase (pol) is capable of catalyzing the bypass of the γ-OH-
PdG adduct 2 in vitro. The major replicative pol in E. coli, pol
III, appeared to be completely incompetent in carrying out this
reaction; DNA synthesis was terminated one nucleotide before
the lesion (83). The ring-opened N2-(3-hydroxypropyl)-dG
model adduct 15 was also a complete block to replication by
pol III (83). Thus, pol III is unlikely to be involved in
intracellular bypass of γ-OH-PdG.
In vitro bypass experiments were conducted with the exo-
nuclease-deﬁcient Klenow fragment (Kf) of pol I to investigate
whether another essential E. coli pol, pol I, can be involved in
bypass of γ-OH-PdG (65, 66). γ-OH-PdG posed a signiﬁcant
block to replication, and when the reactions were performed
with individual deoxynucleotide triphosphates using -1 primers
(the 3′ primer terminus was positioned immediately prior to the
adducted site), incorporation opposite the adduct was most
efﬁcient in the presence of dGTP and dATP but not the correct
dCTP (65, 66). These patterns of misincorporation were very
similar to those previously observed for the ring-closed PdG
adduct 14 (84, 85). The difference in the miscoding propensities
of γ-OH-PdG and PdG became more apparent when the
reactions were conducted using various 0 primers (the 3′ primer
termini are positioned opposite the adducted site) (69). The
primer with dC at the 3′ terminus opposite the γ-OH-PdG adduct
was more readily extended than primers with either dA, dG, or
dT. However, extension on the PdG-containing template was
more efﬁcient from the dT primer terminus than from dA and
dC termini. These data provided valuable insights into the
mechanism of bypass of the γ-OH-PdG adduct, conﬁrming
the hypothesis (52) that the ring opening would facilitate the
efﬁciency and increase the ﬁdelity of translesion synthesis.
However, for the reasons listed below, these data are not
sufﬁciently informative to speculate on a possible role of pol I
in intracellular bypass of this lesion. First, the mutagenic
outcome of replication depends on both the identity of nucle-
otides inserted opposite the adduct and the relative efﬁciencies
of extension from the products of insertion. In the case of γ-OH-
PdG, it is possible that the efﬁcient extension from dC opposite
the adduct will correct the apparent error-prone insertion step,
directing the bypass reaction toward preferential formation of
the error-free products. Second, all of the in vitro studies
described above were performed using exonuclease-deﬁcient Kf
but not the intact pol I. It requires further evaluation whether
the 3′ to 5′ and 5′ to 3′ exonuclease activities of pol I are capable
of correcting the replication errors opposite the γ-OH-PdG
adduct. Finally, it is unknown how the equilibrium is shifted
between the ring-closed and the ring-opened species when the
adduct is subjected to replication in cells. Germane to this
question, Kf exo- only inserted dCTP opposite the ring-opened
N2-(3-hydroxypropyl)-dG model adduct 15.
2 If the rate of the
replication fork progression is faster than the rate of the ring
closure, pol I, if involved, will replicate past the adduct in its
less miscoding form. Thus, the cellular role for pol I in error-
free bypass of the γ-OH-PdG adduct cannot be excluded.
In addition to pol I and pol III, E. coli possesses three DNA
damage-inducible DNA pols; these so-called SOS DNA pols
include pol II (polB), pol IV (dinB), and pol V (umuDC)
(reviewed in ref 86). Whereas the biological function of pol II
is not clearly deﬁned, pol IV and pol V have previously been
shown to be involved in translesion DNA synthesis (TLS).
Recently, the abilities of SOS pols to synthesize DNA past the
γ-OH-PdG adduct 2 and reduced γ-OH-PdG adduct 15 have
been examined (83). Both pol II and pol V were strongly
inhibited by these lesions one nucleotide prior to the site of
modiﬁcation. The blockage was less severe on the DNA
substrate containing the ring-opened, reduced γ-OH-PdG, and
pol II extended a signiﬁcant percentage of the primers past this
lesion to the expected full-size products. The γ-OH-PdG adduct
also blocked pol IV one nucleotide prior to the lesion and
modestly opposite the lesion, but the extent of blockage was
not as strong as in the pol II- and pol V-catalyzed reactions.
The ring-opened, reduced γ-OH-PdG adduct had minimal effect
on DNA synthesis by pol IV. Single-nucleotide incorporation
analyses using a -1 primer revealed that pol IV preferentially
incorporated the correct nucleotide, dC, opposite both of these
lesions.
2 Minko and Lloyd, unpublished data.
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responsible for the replication bypass of γ-OH-PdG, Moriya’s
group (65) utilized an E. coli mutant that lacks all SOS DNA
pols. Vector DNAs containing a site-speciﬁc γ-OH-PdG were
replicated in cells either following stress induction or with no
stress. Under both conditions, no signiﬁcant differences in
bypass efﬁciency were observed relative to the parental strain,
and no effect on the mutagenic outcome was apparent. The
authors concluded that non-SOS pol(s) catalyze(s) error-free
TLS past γ-OH-PdG in E. coli. In view of the recent data
showing the complete inability of pol III to bypass this adduct
(83), pol I seems to be primarily responsible for this function
in vivo.
The ability of Kf to conduct TLS has also been tested for
the R-OH-PdG adduct 3 (69, 87). When primer extensions were
catalyzed by Kf exo+, DNA synthesis was strongly blocked by
R-OH-PdG one nucleotide prior to the lesion and also opposite
the lesion; however, formation of the full-length product was
detected (87). In the Kf exo--catalyzed reactions, limited
extension was observed from the correctly paired 0 primer (dC
opposite the lesion), and the efﬁciency of extension was
comparable to that shown for the PdG adduct 14 (69).
5.2. Replication Bypass of Acrolein-Derived 1,N2-Deoxy-
guanosine Adducts by Eukaryotic DNA Pols. As summarized
in the previous section, the majority of bypass events are error-
free during replication through the γ-OH-PdG adduct 2 in
mammalian cells. The efﬁciency of intracellular bypass of
γ-OH-PdG was estimated to be ∼73% (68). However, γ-OH-
PdG caused mutations at frequencies of ∼3.5-11.0%, specif-
ically when a single-stranded DNA vector was used to assess
the adduct mutagenicity (67, 70, 71). Thus, for the eukaryotic
system, it is important not only to identify the DNA pols that
are involved in bypass of this adduct in vivo but also to evaluate
their potential to contribute to the mutagenic events in this
process.
The majority of the chromosomal DNA in eukaryotic cells
is replicated by two DNA pols, pol ε and pol δ (88). The γ-OH-
PdG lesion 2 strongly blocked synthesis by human pol ε one
nucleotide before the lesion, and following an extremely weak
incorporation opposite the lesion, replication was completely
aborted (67). DNA synthesis by calf thymus pol δ was also
strongly inhibited one nucleotide before γ-OH-PdG, but limited
bypass was observed in the presence of the proliferating cell
nuclear antigen (PCNA) (67). In reactions supplemented with
individual deoxynucleotide triphosphates using a -1 primer,
no insertion opposite the lesion was detected in the presence of
dCTP. However, the primers were extended, even though
inefﬁciently, in the presence of dATP, dGTP, and dTTP. The
ring-opened, reduced γ-OH-PdG adduct 15 also strongly
inhibited the primer extension catalyzed by yeast pol δ (89).
Collectively, these data indicate that pol ε and pol δ are unlikely
to have a major role in synthesizing DNA past γ-OH-PdG in
vivo, and neither of them can signiﬁcantly contribute to the
error-free bypass of this lesion.
The ability to replicate past the PdG adduct 14 was examined
for human pol   (90). This pol plays a role in repair-associated
gap-ﬁlling DNA synthesis (88) and also may be involved in
bypass of certain DNA lesions (91, 92). The bypass of PdG by
this pol was inefﬁcient and highly error-prone. Analysis of the
bypass products revealed that the nucleotide inserted opposite
the lesion site was complementary to the nucleotide on the 5′
side of the PdG lesion of the template strand; subsequently, the
primers were extended, generating products with either mis-
matches or deletions.
On the basis of the above observations, we hypothesized (71)
that in eukaryotes, replication bypass of the γ-OH-PdG adduct
requires the involvement of the specialized TLS pols. To date,
three TLS pols have been identiﬁed in the model eukaryotic
organism, yeast Saccharomyces cereVisiae (88, 93, 94). They
include two members of the pol Y family, pol η and Rev 1,
and one member of the B family, Rev 3, the catalytic subunit
of pol  . Human cells possess two additional Y family pols,
pol ι and pol κ, the latter of which is an orthologue of E. coli
pol IV (88, 93, 94). The potential of eukaryotic TLS pols to
bypass γ-OH-PdG and related model adducts has been exten-
sively investigated and is discussed below.
In contrast to the replicative pols, both the yeast and the
human variants of pol η can replicate past γ-OH-PdG 2 by
incorporating the correct nucleotide, dC, opposite the lesion and
extending the primer beyond a dC paired opposite this adduct
(71). Relative to the nondamaged dG, the efﬁciencies of
incorporation and the subsequent extension were reduced ∼190-
and ∼7.5-fold in reactions catalyzed by yeast pol η and ∼100-
and ∼19-fold in reactions catalyzed by human pol η (71).
Although DNA synthesis past γ-OH-PdG by yeast pol η was
relatively accurate, the human enzyme misincorporated the
purine nucleotides opposite γ-OH-PdG with frequencies of
∼10-1. The PdG adduct 14 strongly blocked synthesis by pol
η, and in the case of the human enzyme, the correct nucleotide,
dC, was incorporated opposite the lesion less efﬁciently than
any of the incorrect nucleotides (71). In contrast, the reduced
γ-OH-PdG adduct 15 was signiﬁcantly less blocking and less
miscoding than γ-OH-PdG. The incorporation of the correct
nucleotide opposite this adduct was especially efﬁcient in
reactions catalyzed by human pol η and was even better than
opposite the nondamaged dG. Thus, these results suggest that
DNA synthesis past γ-OH-PdG by pol η involves the ring-
opened aldehydic form of the lesion. This notion, speciﬁcally
regarding the extension step of the bypass reaction, is consistent
with studies showing that in duplex DNA at neutral pH the
aldehydic form predominated (52).
Replication of a single-stranded DNA vector containing
γ-OH-PdG in wild-type vs pol η-deﬁcient xeroderma pigmen-
tosum variant (XPV) cells revealed a decreased frequency of
base substitutions (71). Alterations in the mutational spectrum
were consistent with biochemical data showing that human pol
η preferentially misincorporated the purine nucleotides opposite
γ-OH-PdG; GfT and GfC transversions but not GfA
transitions were reduced in XPV cells relative to wild-type cells.
Collectively with the observation that nucleotide incorporation
opposite γ-OH-PdG by human pol η was most efﬁcient in the
presence of the correct nucleotide, dC (71), these data suggest
that pol η can contribute to both error-free and mutagenic bypass
of the γ-OH-PdG lesion in cells. When the adduct was
incorporated into a double-stranded vector, frequencies of
mutations in XPV cells were not signiﬁcantly different from
those measured for XPA and HeLa cells (87). Given the very
low overall frequencies of damage-induced mutations in all of
the strains that were utilized in this study, it was not possible
to identify a speciﬁc role for pol η in bypass of the γ-OH-PdG
adduct. However, these data and the results of our study
described above (71) are consistent in demonstrating that in
humans, pol η is not solely responsible for TLS past this lesion.
Pol ι incorporated dC opposite γ-OH-PdG 2 with nearly the
same efﬁciency as opposite a nonadducted template dG;
however, further extension of the primer beyond the lesion was
signiﬁcantly inhibited (95). Interestingly, the relative efﬁciencies
for dC incorporation opposite the ring-closed PdG adduct 14
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equal (89), and they were comparable with that measured for
γ-OH-PdG (95). Therefore, in striking contrast to pol η,i t
appears that ring opening is not required for efﬁcient nucleotide
incorporation opposite γ-OH-PdG by pol ι. Pol ι also incorpo-
rated dT opposite γ-OH-PdG, PdG, and reduced γ-OH-PdG
(89). The efﬁciencies of dT incorporation were ∼3-7 times
less than the corresponding efﬁciencies of dC incorporation,
and these parameters were similar to the relative efﬁciency of
dT incorporation opposite the unmodiﬁed dG.
The ability of pol ι to accommodate and recognize the PdG
adduct 14, which is incapable of Watson-Crick base pairing
and adopts a syn conformation in DNA (42-44), suggested a
unique replication mechanism that involves the utilization of
the Hoogsteen edge of the template dG. The crystallographic
analyses of pol ι ternary complexes showed that, indeed, the
purine bases are “pushed” by the incoming complementary
dNTP from the anti to syn conformation, exposing the Hoog-
steen edge of the template base for nascent base pairing (96).
Similar conformations were also observed for the adducted
purines, 1,N6-etheno-dA and N2-ethyl-dG, within the pol ι active
site (97, 98); however, no crystallographic data on cyclic 1,N2-
dG adducts bound to pol ι have been reported.
Pol ι was unable to extend from a dC placed opposite the
PdG adduct 14 (89). In contrast, the extension efﬁciency from
a dC paired with the reduced γ-OH-PdG adduct 15 was ∼2-
fold higher than from a dC paired with the nondamaged dG.
No signiﬁcant extension was observed from a dT primer
terminus placed opposite either of these two adducts. These
results suggest that ring opening is mandatory for the efﬁcient
extension in pol ι-catalyzed bypass of the γ-OH-PdG adduct 2.
It is not surprising given the fact that, in cocrystal complexes,
the only base that adopts a syn conformation is the template
base of the nascent base pair (96-98). It can be envisioned
that, following incorporation of the anti-oriented dC opposite
the syn-oriented γ-OH-PdG, the adducted base will assume the
regular anti conformation and undergo ring opening oppo-
site the primer dC. Subsequently, such a primer template will
be extended by pol ι, leading to the overall efﬁcient bypass of
the lesion. However, the major site of blockage occurs following
nucleotide incorporation opposite γ-OH-PdG (95). Collectively,
these observations suggest that either the ring opening of the
adduct or the syn to anti rotation of the adducted base about
the glycosyl bond limits pol ι-catalyzed bypass of this lesion.
DNA synthesis by human pol κ was strongly blocked by the
presence of γ-OH-PdG 2 one nucleotide prior to the site of
modiﬁcation (95). However, this pol was able to extend from a
dC opposite the lesion; the efﬁciency of extension was about
3-fold higher than that from a dC opposite the nondamaged dG
(95). Pol κ also efﬁciently and accurately incorporated dC
opposite the ring-opened, reduced γ-OH-PdG adduct 15 and
efﬁciently extended from such a dC (89). In contrast, the ring-
closed PdG adduct 14 represented a severe block to synthesis
by pol κ at both the insertion and the extension step. Thus,
effective TLS past γ-OH-PdG by pol κ is possible only when
the adduct exists in its ring-opened form. This conclusion is in
agreement with the crystallographic analyses of the pol κ
complexes showing that this pol relies on the Watson-Crick
base pairing for the recognition of the template base (99).
At this time, no data have been reported showing pol κ
involvement in cellular bypass of the γ-OH-PdG adduct.
However, evidence has been obtained that strongly supports a
role for pol κ in error-free TLS past various bulky N2-dG adducts
(100-105). The crystallographic analysis of pol κ in the
complex with nondamaged DNA substrate and an incoming
nucleotide revealed that the minor groove portion at the
primer-template junction is quite open (99), which may explain
the tolerance of the pol toward these minor groove lesions.
Taking into consideration that pol κ is able to proﬁciently
replicate through the reduced model adduct 15, we anticipate
this pol has a central role in cellular bypass of γ-OH-PdG when
the adduct enters the replication complex in its ring-opened
form. Additionally, pol κ may extend from a dC that was
inserted opposite the lesion by a different pol, for example, pol
ι. The possibility that pol κ could also extend from a dT opposite
γ-OH-PdG, the consequence of misincorporation by pol ι, was
considered (95) but was ruled out since pol κ was not capable
of extension from a dT placed opposite either γ-OH-PdG, PdG,
or reduced γ-OH-PdG in vitro (89, 95).
Rev1 is a template-dependent deoxycytidyl transferase that
accurately incorporates a dC opposite dG but is not able to
efﬁciently incorporate opposite other template nucleotides (106).
Yeast Rev1 incorporated a dC opposite γ-OH-PdG 2 with an
efﬁciency approaching that for dC incorporation opposite the
nondamaged dG (107). As expected, however, Rev1 failed to
carry out the subsequent extension, with no nucleotide incor-
poration detected opposite the downstream dC. Rev1 incorpo-
rated a dC opposite the PdG adduct 14 with nearly the same
efﬁciency and ﬁdelity as it did opposite the nondamaged dG
(108).
Crystallographic analyses of the ternary complexes of yeast
Rev 1 revealed the structural basis for how this pol promotes
proﬁcient and error-free bypass of exocyclic dG adducts
(108, 109). In the complex with nondamaged DNA substrate,
the template dG is extruded from the DNA helix and held in
this position by hydrogen bonds that are formed between the
Hoogsteen edge of dG and pol amino acids. Incoming dC does
not directly interact with the template dG but pairs with an
arginine residue, thereby ensuring the incorporation of dC over
other incoming nucleotides (109). Signiﬁcantly, Rev1 accom-
modates the template PdG with little or no alteration in structure;
PdG is extruded from the DNA helix in a manner similar to
the nondamaged dG, allowing the proper interactions between
incoming dC and a “surrogate” arginine (108).
Pol   is a protein complex comprised of the catalytic subunit
Rev3 and the accessory subunit Rev7 (93). In contrast to Rev1,
yeast pol   was signiﬁcantly inhibited at the nucleotide insertion
step opposite the γ-OH-PdG adduct 2; the efﬁciency of dC
incorporation was reduced ∼20-fold relative to the nondamaged
control (107). However, this pol was proﬁcient in extending
from a dC opposite the lesion with only ∼3-fold reduction in
efﬁciency relative to the nondamaged control (107). Pol   was
unable to insert nucleotides opposite the ring-closed PdG adduct
14 (108), although it could extend from dC paired with the ring-
closed PdG adduct. However, the efﬁciency of the extension
was ∼35-fold lower than that determined for the corresponding
nondamaged control. On the basis of these observations, it has
been suggested that Rev1 and pol   function sequentially to
bypass γ-OH-PdG and other exocyclic dG adducts (107). It is
worth noting that although ring opening will facilitate the overall
TLS efﬁciency by promoting the pol  -catalyzed extension step,
this structural rearrangement is not absolutely required for the
Rev1/pol  -mediated bypass of the γ-OH-PdG adduct.
From the results of assays in vitro using various eukaryotic
DNA pols, we conclude the following. (1) Error-free bypass of
the ring-opened, aldehyde adduct 1 (R ) H) can be conducted
by either pol η or pol κ, such that insertion opposite the lesion
and subsequent extension are performed by the same pol (two-
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pol η and pol κ is that they make use of the Watson-Crick
geometry for recognition of the template base (99, 110, 111).
In this respect, pol η and pol κ are similar to replicative pols,
but in contrast to the replicative pols, they better tolerate minor
groove perturbations caused by the open form of the γ-OH-
PdG adduct. (2) Error-free bypass of the aldehyde adduct 1 (R
) H) can also be achieved by the sequential action of TLS pols
such that either Rev1 or pol ι will insert opposite the lesion,
while pol  , pol η,o rp o lκ will extend (two-step, two-pol
mechanism). As discussed, pol ι is also able to catalyze the
extension, but its dissociation from the primer template prior
to extension seems necessary. (3) Rev1 or pol ι can initiate error-
free bypass of the ring-closed adduct 2 by insertion of the correct
nucleotide opposite the lesion; these two TLS pols are unique
in that they do not rely on the Watson-Crick geometry for
recognition of the template base. Following the ring opening
and rotation of the adducted base from the syn into the anti
conformation, pol  , pol η,o rp o lκ will catalyze the subsequent
extension. Pol   will likely do so even if the adduct is still in
its ring-closed form. (4) In human cells, pol η contributes to
the mutagenic bypass of the γ-OH-PdG 2 adduct by inserting
dA and dG opposite the ring-closed form of the adduct. Pol ι
may cause mutations by inserting dT opposite either form of
the adduct. Non-TLS pols, for example, pol δ, may also
misincorporate opposite the lesion. Further analyses are required
to identify DNA pols that would be capable of the extension
from the various mismatched primer termini opposite γ-OH-
PdG, thus, potentially contributing to the mutagenic bypass of
this adduct.
The consequences of cellular processing of the R-OH-PdG
adduct 2, such as the extent of the blockage to replication and
the mutational outcome, are remarkably similar to those caused
by the ring-closed PdG adduct 14 (61, 68, 69, 72). Not
surprisingly, the action of many TLS pols on the R-OH-PdG-
containing templates is similar to that of the PdG-containing
templates. Nucleotide insertion opposite the R-OH-PdG adduct
and subsequent extension by calf thymus pol δ in the presence
of PCNA were poor (87). Pol δ was able to resume DNA
synthesis only when the primer terminus was g7 nucleotides
past the R-OH-PdG lesion. The exonucleolytic proofreading
activity of pol δ predominated when the primer terminus was
six or fewer nucleotides past the lesion. Rev1 inserted dC
opposite R-OH-PdG, and pol ι inserted dC and dT, but these
pols could not catalyze the subsequent extension (87). Pol η,
pol κ, and pol   were signiﬁcantly blocked one nucleotide prior
to R-OH-PdG, incorporating incorrect nucleotides opposite this
adduct with a much higher preference over the correct dC. Pol
η and pol   could extend from dC opposite R-OH-PdG but very
inefﬁciently. Pol η, pol  , and pol κ were also able to extend
from various mismatched primer termini opposite R-OH-PdG.
Replication of vector DNA containing R-OH-PdG in pol
η-deﬁcient XPV cells resulted in ∼10-fold reduced frequency
of base substitutions relative to the XPA cells, while the
complementation of XPV cells with pol η activity led to ∼2.4-
fold increased frequency of base substitutions (87). From these
results, it was concluded that pol η was not critical to error-
free bypass of R-OH-PdG, but it signiﬁcantly contributed to
mutagenic bypass. Regarding the accurate TLS past R-OH-PdG
in mammalian cells, in vitro analyses suggest that Rev1 and
pol ι could be involved in the insertion of the correct nucleotide
opposite the adduct. However, it is uncertain which pol(s) would
be able to efﬁciently carry out DNA synthesis beyond this step.
5.3. Replication Bypass of 4-HNE-Derived 1,N2-Deoxy-
guanosine Adducts by Eukaryotic DNA Pols. On the basis
of the observation that proﬁcient and accurate TLS past γ-OH-
PdG can be accomplished by the sequential action of pol ι and
pol κ, it was hypothesized that these pols would also be able to
bypass other exocyclic dG adducts (112). Indeed, pol ι could
incorporate dC opposite the (6S,8R,11S)- and (6S,8R,11R)-4-
HNE-dG adducts 6 and 8 with the efﬁciencies reduced only
∼3-fold relative to that observed for incorporation opposite
nondamaged dG but was not able to carry out the extension. In
contrast to pol ι, pol κ was inhibited at the insertion step, but it
was proﬁcient in extending from the dC primer termini opposite
these lesions. The efﬁciencies of both insertion and extension
by pol κ were dependent on the identity of the lesion. Although
no nucleotide incorporation was detected opposite (6S,8R,11S)-
4-HNE-dG 6, a limited incorporation of dC was observed
opposite (6S,8R,11R)-4-HNE-dG 8. The efﬁciency of extension
from a dC opposite (6S,8R,11S)-4-HNE-dG 6 by pol κ was
reduced ∼5-fold, whereas the efﬁciency of extension from a
dC opposite (6S,8R,11R)-4-HNE-dG 8 was comparable to the
corresponding control value. Overall, these data indicate that
the sequential action of pol ι and pol κ can promote efﬁcient
and error-free TLS past the 4-HNE-1,N2-dG lesions.
The ability of human pol η to bypass 4-HNE-dG lesions was
also examined (112). This pol was strongly inhibited by the
(6S,8R,11S)-4-HNE-dG and (6S,8R,11R)-4-HNE-dG adducts 6
and 8 at both the insertion and the extension steps. In addition,
pol η was prone to misincorporate nucleotides opposite these
lesions. Although pol η was impaired at extending from a dC
opposite both lesions, the blockage was less severe on the
(6S,8R,11R)-4-HNE-dG-containing template than on the
(6S,8R,11S)-4-HNE-dG-containing template; the efﬁciency of
extension was reduced ∼20- and ∼500-fold, respectively.
It is signiﬁcant that, for both pol κ and pol η,( 6 S,8R,11R)-
4-HNE-dG 8 was less inhibitory to DNA synthesis than
(6S,8R,11S)-4-HNE-dG 6, possibly because adduct 8 undergoes
ring opening more readily than adduct 6. Consistent with this
interpretation, (6S,8R,11R)-4-HNE-dG 8 was less miscoding
than (6S,8R,11S)-4-HNE-dG 6 during replication of site specif-
ically modiﬁed vector DNA in COS-7 cells (82).
5.4. Replication Bypass of the Model PdG Adduct by
Sulfolobus solfataricus DNA Pol IV. To elucidate the structural
basis of how replication errors can occur during bypass of enal-
derived 1,N2-dG adducts, structures of ternary pol-DNA-dNTP
complexes were determined for the Y-family S. solfataricus
DNA pol IV (Dpo4) bound to a DNA substrate that contained
the ring-closed PdG adduct 14 at the templating site (113). Three
template 18-mer·primer 13-mer sequences, 5′-d(TCA-
CXAAATCCTTCCCCC)-3′·5′-d(GGGGGAAGGATTT)-3′ (tem-
plate I), 5′-d(TCACXGAATCCTTCCCCC)-3′·5′-d(GGGG-
GAAGGATTC)-3′ (template II), and 5′-d(TCATXGAATCCT-
TCCCCC)-3′·5′-d(GGGGGAAGGATTC)-3′ (template III), where
X ) PdG, were used in crystallographic analyses. With
templates I and II, ternary complexes were obtained with an
incoming dGTP. For template III, a ternary complex was
obtained with an incoming dATP. In each of these three ternary
complexes, the incoming nucleotide (dGTP or dATP) did not
pair with PdG but instead with the 5′-neighboring nucleotide
(dC on templates I and II or dT on template III), utilizing
Watson-Crick geometry; the PdG adduct remained in the anti
conformation about the glycosyl bond. Thus, all three ternary
complexes were of the “type II” structure described for ternary
complexes with native DNA (114). It can be inferred from these
data that one mechanism by which Dpo4 might bypass PdG is
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nucleotide within its spacious active site and incorporating an
incoming nucleotide opposite the 5′-neighboring nucleotide.
Replication bypass experiments with a PdG-containing tem-
plate primer in a Cp(PdG)pA template sequence showed that
Dpo4 inserted dG and dA when challenged by the PdG adduct.
Although the structural basis for incorporation of dA is currently
unknown, insertion of dG presumably reﬂects the “type II”
structure that was observed in crystallographic analyses. These
results provide insight as to how -1 frameshift mutations might
be generated by the PdG adduct. The anticipated mechanism
involves utilization of the 5′-neighboring template nucleotide
for base pairing, a process referred to as dNTP-stabilized
misalignment (115), followed by the subsequent extension.
However, if the primer realigns prior to the extension step,
sequence-dependent base substitutions could occur as a conse-
quence of such replication.
6. Repair of Enal-Derived 1,N2-Deoxyguanosine
Adducts
Identiﬁcation of the biological mechanisms involved in repair
and tolerance of enal-derived 1,N2-dG adducts has been ad-
dressed in several studies, mostly focusing on the NER and base
excision repair (BER) pathways. Although some lesions can
be repaired by either mechanism, NER is primarily responsible
for removal of bulky, structure-perturbing DNA adducts (re-
viewed in ref 116). BER, on the other hand, eliminates a variety
of damaged bases, such as products of deamination, oxidation,
and alkylation, utilizing DNA glycosylases as the initiating
enzymes (reviewed in ref 117).
Marnett’s group investigated the removal of PdG adduct 14
by comparing the mutation frequency and strand bias following
replication of site speciﬁcally modiﬁed M13 genomes in wild-
type and various repair-deﬁcient strains of E. coli (118). The
NER-deﬁcient uVrA- and uVrB- strains, but not the strains
lacking the functional 3-methyladenine glycosylase, displayed
defective processing of PdG. Additionally, reactions were
conducted in vitro to examine whether PdG can be removed
by NER proteins; both E. coli UvrABC excinuclease and
Chinese hamster ovary cell-free extracts were competent in
making dual incisions around the lesion (118).
The cellular processing of γ-OH-PdG 2 was examined in E.
coli using a site speciﬁcally modiﬁed double-stranded vector
that was replicated in wild-type, uVrA-, and recA- strains (65).
Analyses of the progeny DNAs indicated that this adduct was
also excised by the NER pathway. In addition, the block to DNA
synthesis was partially overcome by a RecA-dependent mech-
anism, presumably daughter strand gap repair. Consistent with
the role of bacterial NER in γ-OH-PdG removal, incision of
this adduct was demonstrated in the presence of a reconstituted
prokaryotic NER system of recombinant proteins in which UvrA
and UvrB were derived from Bacillus caldotenax and UvrC from
Thermotoga maritima (119).
Mutagenic properties of γ-OH-PdG 2 were assessed in an E.
coli double mutant, deﬁcient in exonuclease III and endonuclease
IV (66), two major apurinic/apyrimidinic endonucleases associ-
ated with the BER pathway. Suggesting that BER is unlikely
to be involved in the removal of γ-OH-PdG, replication of the
modiﬁed vector did not result in the occurrence of base
substitutions in this mutant.
Kinetics of recognition and repair of 4-HNE-dG lesions were
investigated in human nuclear extracts by monitoring both the
removal of adducts from plasmid DNA substrates and the
subsequent repair-associated DNA synthesis (120). These data
indicated that the repair was NER-dependent with the excision
rates being inﬂuenced by the stereochemistry of lesions;
speciﬁcally, the (6S,8R,11S) and (6S,8R,11R) isomers 6 and 8
were removed faster than the (6R,8S,11R) and (6R,8S,11S)
isomers 7 and 9.
The removal of γ-OH-PdG 2, R-OH-PdG 3, and PdG 14
adducts was assayed in in vitro reactions using site speciﬁcally
modiﬁed duplex oligodeoxynucleotides (69). Following incuba-
tion of these DNA substrates with a BER-competent HeLa cell
extract, no products were detected that would be indicative of
repair initiated by the BER glycosylases.
Thus, the data are consistent in demonstrating the necessity
of NER, but not BER, for the efﬁcient repair of enal-derived
1,N2-dG adducts. Interestingly, in contrast to these six-membered
cyclic adducts, the ﬁve-membered unsaturated cyclic 1,N2-
etheno-dG adduct is a substrate for E. coli mismatch-speciﬁc
uracil DNA glycosylase and the human alkyl-N-purine DNA
glycosylase (121). Additionally, it was observed that both
acrolein and 4-HNE inhibited NER in human cells, suggesting
the synergistic role of DNA adducts and protein damage in enal-
induced carcinogenesis (27, 122).
7. DNA-DNA Cross-Linking by Enal-Derived
1,N2-Deoxyguanosine Adducts
As noted, the aldehydes resulting from the ring opening of
enal-induced 1,N2-dG lesions represent chemically reactive
species within the minor groove of the DNA. DNA cross-linking
was proposed based upon analysis of acrolein-treated DNA (58).
The DNA interstrand cross-linking chemistry of the enal-
mediated 1,N2-dG adducts was recently reviewed (51). It has
been observed that γ-OH-PdG 2 could form reversible, inter-
strand DNA-DNA cross-links (Scheme 4) when placed in a
5′-CpG-3′ sequence context; no cross-link was observed in a
GpC sequence (33). The cross-linked species was observed by
HPLC and capillary gel electrophoresis and initially identiﬁed
by mass spectrometry. The cross-linked dG nucleosides were
identiﬁed from enzymatic digestion of the cross-linked duplex
and fully characterized by independent chemical synthesis. Other
5′-CpG-3′ interstrand cross-links are known, for example, arising
from mitomycin C (123, 124) and nitrous acid (125). An N2-
dG:N2-dG trimethylene linkage 23 (Scheme 4, R ) H), a stable
surrogate for the cross-link, was constructed in a self-
complementary duplex that contained a 5′-GpC-3′ sequence;
NMR analysis showed that its structure was distorted and its
Tm was reduced (126, 127), providing a rationale for why such
a cross-link is not observed in a 5′-GpC-3′ sequence context.
The native interstrand cross-links could potentially exist as
equilibrium mixtures of carbinolamine 20, imine 21, or pyrimi-
dopurinone 22 species (Scheme 4). The cross-links can be
trapped by reduction with sodium borohydride or sodium
cyanoborohydride, suggesting the presence of imine cross-link
21 (33, 128, 129). The nature of γ-OH-PdG to dG interstrand
cross-link was determined by NMR spectroscopy employing
speciﬁc 15N and 13C labels; separate oligodeoxynucleotides were
synthesized in which a 13C label was incorporated at the
aldehyde carbon of the adduct and a 15N2-label of the unmodiﬁed
dG of the complementary strand or an 15N2-label of the modiﬁed
dG. A series of isotope-edited NMR experiments showed that
the major cross-link species in duplex DNA was the carbino-
lamine 20, while the concentrations of the imine 21 and
pyrimidopurinone 22 were below the level of detection
(128, 130, 131).
A clue as to why the acrolein-derived cross-link preferred
the carbinolamine 20 (130, 131) and not the pyrimidopurinone
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an N2-dG:N2-dG trimethylene linkage 23 was constructed in a
self-complementary duplex 5′-d(AGGCXCCT)2, where X rep-
resents the cross-linked dGs 23 (127). The saturated linkage,
which we believe is a reasonable model for the carbinolamine
cross-link, caused minimal distortion of the duplex (127).
Additionally, Tm studies monitored by NMR and modeling
suggestedthatthecarbinolaminelinkagemaintainedWatson-Crick
bonding at both of the cross-linked C·G pairs (131). Dehydration
of carbinolamine 20 to imine 21, or cyclization of the latter to
pyrimidopurinonelinkage22,wouldhavedisruptedWatson-Crick
bonding at one or both of the cross-linked base pairs.
In addition to the formation of interstrand cross-links, the
γ-OH-PdG adduct 2 was shown to form intrastrand cross-links
(129). These were detected when the adduct was located 3′ next
to the nick in the DNA, whereas a dG, dT, dA, or deoxyinosine
was placed 5′ to the nick. Intra- vs interstrand cross-linking was
distinguished by the electrophoretic mobilities of the products
after sodium borohydride reduction. Because cross-links were
formed even in the absence of readily identiﬁable reactive
nucleophiles on the base across the nick, it seems plausible that
the cross-linking occurred with other, more distant bases.
Interstrand cross-link formation of the crotonaldehyde and
4-HNE adducts was highly dependent upon adduct stereochem-
istry. After >20 days, ∼38% cross-link formation occurred for
the (6R,8R)-crotonaldehyde adduct 4, whereas <5% cross-link
was observed for the (6S,8S)-diastereomer 5 (33). Isotope-edited
NMR spectroscopy established that the carbinolamine form of
the (6R,8R) cross-link was the only detectable cross-link species
present in duplex DNA (35). NMR studies of the (6S,8S)
diastereomer 5 at pH 9.3, which favor the ring-opened aldehyde,
showed that the aldehydic group was oriented in the 3′ direction
within the minor groove (35, 132).
Structural studies utilizing saturated analogues of the (6R,8R)-
and (6S,8S)-crotonaldehyde cross-links indicated that both
retained Watson-Crick hydrogen bonds at the cross-linked base
pairs (133). However, the (6S,8S)-diastereomer 5 showed lower
stability. Whereas the CH3 group of the (6R,8R)-diastereomer
4 was positioned in the center of the minor groove, it was
positioned in the 3′ direction for the (6S,8S)-diastereomer and
interfered sterically with the DNA duplex structure (133). These
results were consistent with modeling of the native cross-links
(35).
Of the four 4-HNE adducts, only the one with the (6S,8R,11S)
conﬁguration formed an interstrand cross-link in the 5′-CpG-3′
sequence (34). The (6S,8R,11S) diastereomer 6 possesses the
same relative C6 stereochemistry as the (6R,8R) crotonaldehyde
adduct 4 (Figure 1), which also formed interstrand cross-links;
these observations suggest that the adduct stereo chemistry is
an important consideration in modulating interstrand cross-
linking. Although cross-linking proceeded slowly, after 2
months, the yield was a remarkable ∼85%. The conformations
of the cyclic hemiacetals corresponding to the (6S,8R,11S)- and
(6R,8S,11R)-HNE-dG adducts 6 and 7 (Figure 5) were examined
in a CpG sequence context (134). Both diastereomers were
located within the minor groove of the duplex; the cyclic
hemiacetal 27 derived from the (6S,8R,11S)-HNE adduct was
oriented in the 5′ direction, while the cyclic hemiacetal 28
derived from the (6R,8S,11R)-HNE adduct was oriented in the
3′ direction. These differences in orientation suggest a structural
basis that explains, in part, why the (6S,8R,11S)-diastereomer
6 forms interstrand cross-link in the 5′-CpG-3′ sequence,
whereas the (6R,8S,11R)-diastereomer 7 does not. Spectroscopic
studies to delineate the cross-linking chemistry of the HNE
adducts are continuing.
8. Biological Processing of DNA-DNA Cross-Links
Mediated by Enal-Derived 1,N2-Deoxyguanosine
Adducts
DNA interstrand cross-links represent one of the most serious
types of DNA damage, since fundamental biological processes,
such as replication and transcription, require transitory separation
of the complementary DNA strands. In higher eukaryotes, repair
of interstrand cross-links requires the cooperation of multiple
proteins that belong to different biological pathways, including,
but not limited to, NER, homologous recombination, TLS,
double-strand break repair, and the Fanconi anemia pathway
(reviewed in refs 135-138). A current model for interstrand
cross-link repair suggests that this process is initiated by dual
incision around the cross-link of one of the two affected strands.
The dual incision, or “unhooking”, depends on NER in E. coli
(139-142). In mammalian systems, various proteins have been
suggested to be involved in this process and, in particular, the
XPF/ERCC1 complex (143), a structure-speciﬁc endonuclease
and a component of NER. The result of the dual incision is a
gap that can subsequently be ﬁlled by either TLS or pairing of
the 3′ end of the preincised strand with the homologous
sequence, followed by DNA synthesis. In the former case, the
complementary strand with the cross-link still attached is used
as a template. Once the integrity of one DNA strand is restored,
the second strand can be repaired by a conventional NER
mechanism. When repair is concomitant with replication, a DNA
double-strand break can be formed; thus, additional enzymatic
activities are required to tolerate interstrand cross-links.
As discussed above, the enal-mediated DNA interstrand cross-
links are chemically reversible. Consequently, the extent to
which they are present in vivo and their potential to alter the
biological processing of the enal-derived adducts remain to be
determined. These problems represent an area of intense ongoing
investigation. Studies to date have utilized the enal-mediated
N2-dG:N2-dG interstrand cross-links as well as their chemically
stable saturated analogues 23 as tools to address important
questions on both molecular mechanisms of interstrand cross-
link repair and biological consequences of this repair.
The saturated cross-link 23 (R ) H) has been incorporated
into a linear DNA fragment to investigate the processing of
interstrand cross-links by the XPF/ERCC1 heterodimer (144).
In the presence of RPA, XPF/ERCC1 acted as a 3′ to 5′
exonuclease; the progression of the exonuclease activity was
attenuated at the cross-linked site. On the basis of this
observation, the authors proposed a role for XPF/ERCC1 in the
processing of a double-strand break that could be created when
a cross-link encounters the replication fork.
Moriya and co-workers examined the repair of the crotonal-
dehyde-derived N2-dG:N2-dG interstrand cross-links following
replication of site speciﬁcally modiﬁed vector DNAs in various
E. coli and mammalian cells (145). The cross-links were
positioned in a 5′-CpG-3′ sequence context. In a NER-deﬁcient
UVrA- E. coli mutant, vectors containing the stable, reduced
cross-link 23 (Scheme 4, R ) CH3) failed to yield transformants.
Vectors adducted with the corresponding nonreduced cross-links
did yield transformants under these conditions, suggesting that
the native cross-links reverted at least partially to noncross-
linked N2-dG lesions in the NER-deﬁcient host. However, in
NER-proﬁcient E. coli, comparable numbers of transformants
were obtained from either type of plasmid, regardless of whether
the cross-link was reduced or not. This result conﬁrmed the
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links in E. coli (139, 142). In human XPA cells, the reduced
cross-link was removed, suggesting the presence of a repair
pathway unique to higher eukaryotes that does not require the
initial damage recognition by NER. This repair was not coupled
with transcription but was associated with replication. On the
basis of recovery of progeny DNAs from wild-type cells and
XPA cells, the authors concluded that although the NER-
independent pathway signiﬁcantly contributed to the repair, NER
still played a major role. The analyses of recovered DNA
molecules revealed that the native and reduced cross-links were
modestly miscoding (6% of mutations or less) in both E. coli
and mammalian cells, with GfT transversions predominating.
The cross-linked dG located in the lagging strand was the
primary site of mutations. These observations are consistent with
a model for interstrand cross-link repair by a recombination-
independent pathway and provide important information regard-
ing the initiating steps of this process. The authors’ interpretation
of the data was that in human cells, NER is acting to “unhook”
strands on nonreplicating DNA, while at the replication fork,
incisions around the cross-link can be generated by a structure-
speciﬁc endonuclease, for example, XPF/ERCC1, independently
of NER. This is an interesting idea that requires further
validation.
Using site speciﬁcally modiﬁed vector DNAs, the ﬁdelity of
recombination-independent repair was also assessed for the
reduced acrolein-mediated N2-dG:N2-dG interstrand cross-link
23 (Scheme 4, R ) H). Replication of DNAs containing this
lesion was accurate in ∼97% of bypass events in COS-7 cells
(146). GfT transversions were the only mutations detected
when the cross-link was positioned in a CpG sequence, a result
that is in agreement with data on mutagenic properties of the
crotonaldehyde-mediated cross-links (145). Interestingly, the
same acrolein-mediated cross-link in a GpC sequence context
caused predominantly short deletions (<15 nucleotides) and
GfA transitions. In wild-type E. coli, no mutations were found
in 52 analyzed DNA clones that originated from vectors
containing acrolein-mediated cross-link 23 in the CpG sequence
(147). Thus, in both bacterial and mammalian systems, stable
analogues of the acrolein- and crotonaldehyde-mediated N2-dG:
N2-dG interstrand (23) cross-links are processed by a recom-
bination-independent mechanism in a largely error-free manner.
In TLS-dependent repair of interstrand cross-links, these pols
are recruited presumably to carry out gap-ﬁlling replication
through the cross-link site. On the basis of a number of
observations, Rev1 and pol   have been proposed to conduct
this reaction in eukaryotes. Indeed, deﬁciency in either of these
activities confers hypersensitivity to DNA cross-linking agents
(148-150) and results in less efﬁcient but more accurate cellular
processing of interstrand cross-links (151). However, until very
recently, no biochemical data have existed showing the abilities
of Rev1 and pol   to bypass aberrant DNA structures that could
be formed as intermediates in the interstrand cross-link repair.
With synthetic chemical strategies for the construction of
oligodeoxynucleotides containing the reduced acrolein-mediated
N2-dG:N2-dG interstrand cross-links, we prepared a series of
DNA substrates that mimic potential repair intermediates (ICL1-
ICL4, Figure 3) and examined the abilities of various DNA pols
to replicate past the cross-linked sites (146). The data revealed
that yeast Rev1 was quite efﬁcient at inserting the correct
nucleotide, dC, opposite the cross-linked dG in ICL4 but, as
expected, could not carry out DNA synthesis beyond this site.
Yeast pol   was incapable of nucleotide incorporation opposite
the cross-linked dG in any of the DNA substrates examined,
and it was strongly inhibited at the extension step. In the
presence of Rev1, which is known to stimulate pol   activity
(152), pol   inefﬁciently extended primers containing the
mismatched terminal nucleotides opposite the cross-linked dG;
extension from the correctly paired dC was barely detectable.
Although the data are consistent with the proposed role for Rev1
in TLS past interstrand cross-links, no evidence was found
showing an ability of pol   to catalyze this reaction. Given the
cellular role for pol   in recombination-independent repair of
mitomycin C-induced cross-links (151) and the structural
similarity between mitomycin C-induced cross-links and inter-
strand cross-links that were used in replication assays in vitro
(stable analogues of the acrolein-mediated N2-dG:N2-dG cross-
link in a CpG sequence context), the latter observation is
surprising. Thus, the possibility should be considered that the
major function of pol   in TLS past N2-dG:N2-dG interstrand
cross-links is not DNA synthesis per se but rather facilitation
of this process. For example, this might occur by recruiting other
TLS pols or scaffolding the TLS machinery.
In contrast to pol  , human pol κ not only catalyzed accurate
incorporation opposite the cross-linked dG but also replicated
beyond the lesion (146). The efﬁciency of the bypass reaction
was signiﬁcantly enhanced by truncation of the 3′ end of the
nontemplate strand (ICL3, Figure 3), and it was further enhanced
by truncation of the 5′ end (ICL4, Figure 3). Steady-state kinetic
parameters were measured for ICL4; relative to the nondamaged
dG, the efﬁciency of dC incorporation opposite the cross-linked
dG was reduced ∼35-fold, whereas the efﬁciency of extension
from dC opposite the lesion was reduced ∼7-fold. E. coli pol
IV, an orthologue of human pol κ, could carry out the same
bypass reaction on DNA templates containing the reduced
acrolein-mediated N2-dG interstrand cross-links as well (147).
The efﬁciency of dC incorporation opposite the cross-linked
dG in ICL4 was reduced ∼50-fold relative to that observed for
the nondamaged dG, and the extension efﬁciency from dC
opposite the lesion was reduced ∼2-fold. E. coli pol II was
unable to catalyze TLS past these cross-links (147).
The reduced acrolein-mediated N2-dG:N2-dG interstrand
cross-link was site speciﬁcally incorporated into a DNA vector,
and this modiﬁed vector was utilized to transform wild-type E.
coli strain and pol II and pol IV deletion mutants (147). Whereas
the transformation efﬁciency of a pol II-deﬁcient strain was
Figure 3. Oligodeoxynucleotides containing the reduced acrolein-
mediated N2-dG:N2-dG interstrand cross-link (23).
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replicate the modiﬁed DNA was nearly abolished in a pol IV-
deﬁcient strain. Furthermore, following exposure to mitomycin
C, both the pol IV-deﬁcient E. coli and the pol κ-depleted human
ﬁbroblasts cells showed decreased survival relative to corre-
sponding controls (146, 147). In addition, the extent of
chromosomal aberrations was signiﬁcantly elevated in pol
κ-depleted vs control ﬁbroblasts following mitomycin C treat-
ment (146). Combined, these data strongly suggest that DNA
pols of the DinB family, E. coli pol IV and human pol κ, are
key components of TLS-assisted repair of N2-dG:N2-dG inter-
strand cross-links.
Overall, the recent progress in developing chemical strategies
to synthesize the enal-mediated interstrand cross-link models
made investigations into the biology of these lesions using site-
speciﬁc approaches possible. Site speciﬁcally modiﬁed oligode-
oxynucleotides containing enal-mediated interstrand cross-links
have been proven to be an indispensable tool that not only
allowed the validation of existing models for interstrand cross-
link repair but also led to the discovery of new functions of the
previously known enzymatic activities and the formulation of
further hypotheses.
Chemically stable intrastrand cross-links were also utilized
as tools in biochemical investigations. The reduced cross-link
model of the acrolein-derived intrastrand cross-link 23 (R )
H) was examined in replication assays in vitro with E. coli pols
I, II, and III (153). Primer extension experiments showed major
blockage of all three pols one nucleotide prior to the ﬁrst dG
of the cross-link; only pol I was able to incorporate a nucleotide
opposite the ﬁrst dG with no incorporation being detected
opposite the second cross-linked dG. The intrastrand cross-link
23 was shown to be a substrate for the E. coli UvrABC NER
complex (153). The extent of incision of this three-carbon cross-
link was signiﬁcantly less than that observed for the more
structurally perturbed two-carbon cross-link (153).
9. DNA-Protein Conjugation Mediated by
Enal-Derived 1,N2-Deoxyguanosine Adducts
Acrolein and crotonaldehyde cross-link histones with DNA
in vitro (154) and induce DNA-protein cross-links in
cultured human cells (155-157). The chemistry underlying
the formation of these cross-links has not been elucidated,
but a mechanism has been proposed that involves the
conjugation of proteins to the ring-opened aldehyde form of
1,N2-dG exocyclic lesions in duplex DNA (Scheme 4). The
feasibility of such a mechanism was tested in vitro using
site speciﬁcally modiﬁed oligodeoxynucleotides. Indeed,
γ-OH-PdG 2 formed complexes with histones, T4 pyrimidine
dimer glycosylase/abasic site lyase, EcoRI endonuclease, and
various synthetic peptides (72, 131, 158-160). The crotonal-
dehyde-modiﬁed 1,N2-dGs 4 and 5 formed complexes with
peptides (158) and topoisomerase I (Top1) (161); in either case,
the efﬁciency of the reaction was independent of the adduct
stereochemistry. The 4-HNE 1,N2-dG lesions 6-9 were also
reactive toward peptides with the highest cross-linking capacity
observed for the (6S,8R,11S) diastereomer 6 followed by the
(6R,8S,11R)diastereomer7(158).Theseenal-derivedDNA-protein
and DNA-peptide cross-links were stabilized by reduction with
sodium cyanoborohydride; as expected, pretreatment of the
DNA with the reducing agent abolished complex formation.
Thus, the linkage was mediated by carbinolamine/imine chem-
istry (Scheme 4). For the KWKK and RWRR peptides, the
N-terminal R-amine was identiﬁed as the primary reactive
nucleophile involved in linkage formation, although alternative
linkages, particularly via the ε-amino group of lysine residues,
have been proposed (158, 160). In contrast to γ-OH-PdG 2,
the R-OH-PdG adduct 3 was not reactive toward peptides and
proteins (72). Overall, these observations are consistent with
the hypothesis that generation of the enal-induced DNA-protein
cross-links (or at least a subset thereof) could be initiated in
the cell by formation of aldehydic DNA adducts followed by a
secondary modiﬁcation, such as conjugation of proteins via their
N-terminal or side chain nucleophiles.
In addition to the formation of an imine type complex
between the crotonaldehyde 1,N2-dG and Top1, the presence
of the adduct indirectly altered the cleavage and religation
activities of Top1 (161) by suppressing the formation of Top1
cleavage complexes and inducing both reversible and ir-
reversible cleavage complexes adjacent to the adduct. The
formation of the imine DNA-Top1 conjugates and the
induction of Top1 cleavage complexes by crotonaldehyde
1,N2-dG were mutually exclusive. Crotonaldehyde induced
the formation of DNA-Top1 complexes in mammalian cells,
which suggested a potential relationship between the forma-
tion of direct or indirect DNA-Top1 conjugates and the
mutagenic and carcinogenic properties of crotonaldehyde.
An interesting ﬁnding reported by Sako and co-workers
is that formation of adducts 4 and 5 from the reaction of dG
with crotonaldehyde or acetaldehyde could be accelerated
by amino acids (162, 163). Arginine was found to be a
particularly efﬁcient catalyst. The mechanism is believed to
involve Michael addition of N2-dG to the Schiff base complex
between arginine and crotonaldehyde. Schiff base formation
has been shown to accelerate a number of organic reactions,
including Michael additions (164). It was subsequently found
that the formation of 4 and 5 in calf thymus DNA could be
accelerated by the presence of arginine or histones (165, 166).
These results suggest that DNA-peptide or DNA-protein
cross-link formation by enals may involve initial peptide or
protein adducts. This mechanism is consistent with the
observation by Voitkun and Zhitkovich who reported that
DNA-histone cross-links mediated by malondialdehyde
initially involved formation of a malondialdehyde-histone
adduct, followed by reaction with DNA (167).
10. Biological Processing of DNA-Peptide
Cross-Links Mediated by the γ-OH-PdG Adduct
Current data suggest that DNA-peptide cross-links are
formed in cellular DNA not only by damage-induced covalent
attachment of endogenous peptides to DNA but also as
intermediates in the repair of DNA-protein cross-links
(168-172). Cross-links between γ-OH-PdG 2 and peptides were
reduced with cyanoborohydride, and these irreversible substrates
26 (Scheme 4, R ) H) were used as a model to investigate the
biological role and processing of such native DNA-peptide
cross-links (70, 83, 119).
It has been hypothesized that unrepaired DNA-peptide cross-
links could be bypassed by cellular replication machinery,
promoting lesion-induced mutagenesis. Mutagenic properties of
the KWKK tetrapeptide, which was irreversibly cross-linked
to the γ-OH-PdG adduct, were assessed following replication
of site speciﬁcally modiﬁed single-stranded pMS2 vector (70).
Replication bypass in COS-7 cells resulted in mutations at the
site of modiﬁcation at an overall frequency of ∼8.4%; GfT
transversions were most common, but other targeted point
mutations were also detected. In addition, point mutations were
observed at low frequencies at both 5′ and 3′ adjacent nucle-
otides. Replication bypass of the cross-link was less accurate
772 Chem. Res. Toxicol., Vol. 22, No. 5, 2009 Minko et al.than that of the parent γ-OH-PdG adduct 2 (∼3.5% of
mutations), while the spectra of mutations caused by these
lesions were very similar. The peptide cross-link was ∼10 times
more mutagenic than the ring-opened, reduced γ-OH-PdG 15.
These data indicated that although the mammalian replication
machinery has a capacity to bypass bulky N2-propyl-dG-peptide
lesions, the ﬁdelity of this replication can be compromised;
consequently, secondary modiﬁcations of the enal-derived 1,N2-
dG adducts with peptides or proteins may lead to increased
mutagenesis.
The mutagenic properties of the model N2-propyl-dG cross-
links 26 with either the KWKK tetrapeptide or the KFHEK-
HHSHRGY dodecylpeptide were also assessed in E. coli (83).
Both lesions were weakly mutagenic, inducing mutations at
frequencies that were comparable with frequencies observed
for the γ-OH-PdG adduct (∼1%). Thus, relative to mam-
malian cells, E. coli seems to be more competent in providing
accurate bypass of bulky N2-propyl-dG-peptide cross-links.
Replication assays were conducted in vitro to identify DNA
pols capable of TLS past the model N2-propyl-dG-peptide
cross-links 26 (83). Because DNA pols of the DinB family were
implicated in accurate bypass of various bulky N2-dG adducts
(100-105), E. coli pol IV and human pol κ were the focus of
these studies. Both pol κ and pol IV were not only able to
replicate past tetrapeptide (KWKK) and dodecylpeptide (KF-
HEKHHSHRGY) cross-links but also did so in an error-free
manner (83). When similar experiments were conducted with
E. coli pols, pol II, pol III, and pol V, none of them could insert
nucleotides opposite the cross-links, even though a limited
bypass of γ-OH-PdG and reduced γ-OH-PdG was observed in
pol II- and pol V-catalyzed reactions. Consistent with a role of
DinB family pols in tolerance of N2-propyl-dG-peptide cross-
links, the replication efﬁciency of DNA vectors containing these
lesions was greatly reduced in a pol IV-deﬁcient E. coli mutant.
Collectively with the observation that pol IV was not absolutely
required for the efﬁcient bypass of the γ-OH-PdG adduct, these
data are suggestive of the differential cellular processing of the
primary enal-derived 1,N2-dG adducts vs their secondary
modiﬁcation products.
To elucidate a potential role for the NER pathway in removal
of DNA-peptide cross-links, initiation of repair was examined in
vitro by incubation of oligodeoxynucleotides containing the site-
speciﬁc model N2-propyl-dG-tetrapeptide (KWKK) and dode-
cylpeptide (KFHEKHHSHRGY) cross-links 26 with recombinant
NER proteins UvrA and UvrB from B. caldotenax and UvrC from
T. maritima (119). DNA incision required the coordinated action
of all three proteins and occurred at the eighth phosphodiester bond
5′ to the lesions, consistent with the UvrABC catalytic activity for
known NER substrates. The incision of these DNA-peptide cross-
links was signiﬁcantly more efﬁcient than the incision of γ-OH-
PdG and comparable to that observed for the ﬂuorescein adduct,
an excellent substrate for UvrABC. In parallel, reactions were
conducted with DNA-peptide cross-links that were engineered via
linkages at an abasic site. Demonstrating that the site of attachment
on the DNA can affect the efﬁciency of removal of DNA-peptide
cross-links, peptide adducts on an abasic site were incised faster
than the corresponding γ-OH-PdG-mediated adducts.
Although the reduced cross-links 23 and 26 have been
regarded as model DNA substrates, the imine derived from
condensation of N2-dG and acetaldehyde can be reduced to N2-
ethyl-dG by a combination of glutathione and ascorbate at the
nucleoside level and in calf thymus DNA (173-177). It is
therefore possible that the reduced enal-mediated cross-links
are biologically relevant and present in cells at low levels.
11. Concluding Remarks
The factors affecting the biological processing of DNA
lesions formed as a result of exposure to environmental and
endogenous genotoxicants are extraordinarily complex due
to (1) the production of multiple chemical species during
bioactivation, (2) differential reactivity with DNA as inﬂu-
enced by sequence context effects and the degree of
chromatin condensation, (3) the availability and accessibility
of DNA repair and tolerance proteins to process the lesions,
and (4) the replication status of the cells. However, as this
review has highlighted, attempts to gain fundamental under-
standings of the chemical and biological complexities as-
sociated with DNA adducts of R, -unsaturated aldehydes are
further complicated due to the changing chemical equilibria
of many of these adducts. Studies described herein have
revealed that the 1,N2-dG adducts of enals (acrolein, cro-
tonaldehyde, and 4-HNE) interconvert between ring-closed
and ring-opened species. Models for the ring-closed (PdG,
14) and ring-opened (N2-hydroxypropyl-dG, 15) forms were
used to probe their differential processing by DNA pols in
vitro and during cellular replication. These investigations
provided strong support for the idea that the equilibria
between ring-opened and -closed forms of the enal-derived
1,N2-dG adducts are likely to modulate DNA polymerization
past these sites, which in turn affects mutation rates.
The ring-opened aldehydic form has been demonstrated
to react with other sites in DNA (forming inter- and
intrastrand cross-links) and peptides and proteins (creating
DNA-peptide and -protein conjugates). The imine cross-
linked species were converted into stable model lesions (23
and 26) that were used to investigate the cellular processes
associated with repair and replication of cross-links. These
studies have revealed that NER is highly efﬁcient in the
removal of DNA-peptide adducts. Further investigations
have demonstrated that cells are generally accurate in
replicating DNAs containing DNA-DNA cross-links and
DNA-peptide conjugates, with mutation frequencies being
remarkably low. Both in vitro and cellular replication bypass
analyses have identiﬁed potential DNA pols that may catalyze
these reactions. Given the ease of the interconversion of the
enal-N2-dG cross-linked species in vitro, they likely represent
a substantial fraction of enal-induced adducts in cellular DNA
and may affect replication, repair, and other biological
processes. The detection of these secondary lesions in vivo
and evaluation of their contribution to the genotoxic and
mutagenic effects of acrolein, crotonaldehyde, and 4-HNE
will be important directions for future investigations.
Additional signiﬁcant unanswered questions regarding the
biological processing of the enal-derived 1,N2-dG adducts
include (1) how does the mutagenic spectrum change when
these lesions are formed in repetitive sequences and other
mutational hot spots; (2) what is the efﬁciency by which these
lesions are removed from DNA in human cells, especially
under conditions where NER is inhibited by the enal
compounds; and (3) how are these adducts repaired in
individuals who suffer from NER deﬁciency, such as XP
patients? The ultimate goal for biological studies of enal-
derived 1,N2-dG adducts is to elucidate to what extent they
are linked to the etiology of various cancers, neurological
diseases, and metabolic disorders.
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